Professional
Added to YB: 2026-04-08
Pitch date: 2026-04-02
DVYSR.ST [neutral]
Devyser Diagnostics AB (publ)
-3.63%
current return
Author Info
No bio for this author
Company Info
Devyser Diagnostics AB (publ) engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.
Market Cap
SEK 1.3B
Pitch Price
SEK 77.20
Price Target
N/A
Dividend
N/A
EV/EBITDA
38.26
P/E
-151.57
EV/Sales
5.04
Sector
Biotechnology
Category
growth
Protean Small Cap Portfolio Holding: Devyser
DVYSR.ST (holding update): Genetic testing co down 33% YTD, trading below 2021 IPO price despite nearing cash-flow breakeven & strong growth prospects. DNA-based disease risk/detection tests are sticky but slow to adopt. Market may have overestimated adoption speed.
Read full article (1 min)